255 related articles for article (PubMed ID: 7546912)
1. Passive immunization of rhesus macaques against SIV infection and disease.
Gardner M; Rosenthal A; Jennings M; Yee J; Antipa L; Robinson E
AIDS Res Hum Retroviruses; 1995 Jul; 11(7):843-54. PubMed ID: 7546912
[TBL] [Abstract][Full Text] [Related]
2. Passive immunization of macaques against SIV infection.
Gardner MB; Rosenthal A; Jennings M; Yee JA; Antipa L; MacKenzie M
J Med Primatol; 1994; 23(2-3):164-74. PubMed ID: 7966232
[TBL] [Abstract][Full Text] [Related]
3. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.
Schlienger K; Montefiori DC; Mancini M; Rivière Y; Tiollais P; Michel ML
J Virol; 1994 Oct; 68(10):6578-88. PubMed ID: 7521918
[TBL] [Abstract][Full Text] [Related]
5. Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251.
Kent KA; Kitchin P; Mills KH; Page M; Taffs F; Corcoran T; Silvera P; Flanagan B; Powell C; Rose J
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):189-94. PubMed ID: 8198871
[TBL] [Abstract][Full Text] [Related]
6. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
[TBL] [Abstract][Full Text] [Related]
7. Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.
Mascola JR; Lewis MG; VanCott TC; Stiegler G; Katinger H; Seaman M; Beaudry K; Barouch DH; Korioth-Schmitz B; Krivulka G; Sambor A; Welcher B; Douek DC; Montefiori DC; Shiver JW; Poignard P; Burton DR; Letvin NL
J Virol; 2003 Oct; 77(19):10348-56. PubMed ID: 12970419
[TBL] [Abstract][Full Text] [Related]
8. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
Connor RI; Montefiori DC; Binley JM; Moore JP; Bonhoeffer S; Gettie A; Fenamore EA; Sheridan KE; Ho DD; Dailey PJ; Marx PA
J Virol; 1998 Sep; 72(9):7501-9. PubMed ID: 9696847
[TBL] [Abstract][Full Text] [Related]
9. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
[TBL] [Abstract][Full Text] [Related]
10. Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus.
Stahl-Hennig C; Voss G; Dittmer U; Coulibaly C; Petry H; Makoschey B; Cranage MP; Aubertin AM; Lüke W; Hunsmann G
AIDS; 1993 Jun; 7(6):787-95. PubMed ID: 8363756
[TBL] [Abstract][Full Text] [Related]
11. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
12. Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protects against SIVagm infection in the African green monkey natural host.
Siegel F; Kurth R; Norley S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):217-26. PubMed ID: 7532099
[TBL] [Abstract][Full Text] [Related]
13. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile.
Haigwood NL; Watson A; Sutton WF; McClure J; Lewis A; Ranchalis J; Travis B; Voss G; Letvin NL; Hu SL; Hirsch VM; Johnson PR
Immunol Lett; 1996 Jun; 51(1-2):107-14. PubMed ID: 8811353
[TBL] [Abstract][Full Text] [Related]
14. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.
Clements JE; Montelaro RC; Zink MC; Amedee AM; Miller S; Trichel AM; Jagerski B; Hauer D; Martin LN; Bohm RP
J Virol; 1995 May; 69(5):2737-44. PubMed ID: 7707496
[TBL] [Abstract][Full Text] [Related]
15. Specific and non-specific immunity and protection of macaques against SIV infection.
Le Grand R; Vogt G; Vaslin B; Roques P; Théodoro F; Aubertin AM; Dormont D
Vaccine; 1992; 10(12):873-9. PubMed ID: 1455913
[TBL] [Abstract][Full Text] [Related]
16. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV.
Marthas ML; Sutjipto S; Higgins J; Lohman B; Torten J; Luciw PA; Marx PA; Pedersen NC
J Virol; 1990 Aug; 64(8):3694-700. PubMed ID: 2164591
[TBL] [Abstract][Full Text] [Related]
17. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus.
Ahmad S; Lohman B; Marthas M; Giavedoni L; el-Amad Z; Haigwood NL; Scandella CJ; Gardner MB; Luciw PA; Yilma T
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):195-204. PubMed ID: 8198872
[TBL] [Abstract][Full Text] [Related]
18. Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.
Mills KH; Page M; Chan WL; Kitchin P; Stott EJ; Taffs F; Jones W; Rose J; Ling C; Silvera P
J Med Primatol; 1992; 21(2-3):50-8. PubMed ID: 1433267
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
20. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.
Mascola JR; Stiegler G; VanCott TC; Katinger H; Carpenter CB; Hanson CE; Beary H; Hayes D; Frankel SS; Birx DL; Lewis MG
Nat Med; 2000 Feb; 6(2):207-10. PubMed ID: 10655111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
